The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2021 | Is there a role for consolidation therapy in myeloma?
Nico Gagelmann, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, shares his insights on the role of consolidation therapy in patients with multiple myeloma. Despite having been included in several recent trials where it was shown to deepen responses, consolidation therapy is not approved in any country and its role remains unclear. Dr Gagelmann comments on the need for studies focusing specifically on addressing this question. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.
